Overview

Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma

Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Hepatocellular carcinoma (HCC)is the most frequent primitive tumour of the liver. Recently, several research studies reported that 11C-choline PET has shown a high detection rate of well differentiated HCC, which is an early stage of primary liver cancer. The aim of this study was to prospectively evaluate the diagnostic accuracy of 11C-choline PET-CT to detect HCC in cirrhotic or non cirrhotic patients.
Phase:
Phase 2
Details
Lead Sponsor:
Commissariat A L'energie Atomique
Collaborator:
Assistance Publique - Hôpitaux de Paris
Treatments:
Choline